Search Results - "Wiese, Signe"

Reply to Cailes et al by Danielsen, Karen Vagner, Wiese, Signe, Hove, Jens Dahlgaard, Møller, Søren, Bentsen, Flemming

“…Furthermore, because we do not have follow-up data, we cannot rule out underlying cardiac dysfunction as a contributing factor in HRS-AKI. In the new CCM…”
Get full text

Cirrhotic cardiomyopathy: pathogenesis and clinical relevance by Wiese, Signe, Hove, Jens D., Bendtsen, Flemming, Møller, Søren

“…Key Points Cirrhotic cardiomyopathy is an abnormal cardiac function at rest and an impaired contractile responsiveness to stress in patients with cirrhosis An…”
Get full text

Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study by Danielsen, Karen Vagner, Wiese, Signe, Busk, Troels, Nabilou, Puria, Kronborg, Thit Mynster, Petersen, Claus Leth, Hove, Jens Dahlgaard, Møller, Søren, Bendtsen, Flemming

“…Arterial vasodilation and hyperdynamic circulation are considered hallmarks of the pathophysiological mechanisms of decompensation in cirrhosis. However,…”
Get full text

How non-alcoholic fatty liver disease and cirrhosis affect the heart by Møller, Søren, Wiese, Signe, Barløse, Mads, Hove, Jens D.

“…Liver diseases affect the heart and the vascular system. Cardiovascular complications appear to be a leading cause of death in patients with non-alcoholic…”
Get full text

Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome by Wiese, Signe, Hove, Jens, Mo, Silje, Mookerjee, Rajeshwar P., Petersen, Claus L., Vester‐Andersen, Marianne K., Mygind, Naja D., Goetze, Jens P., Kjær, Andreas, Bendtsen, Flemming, Møller, Søren

“…Background & Aims The underlying pathogenesis of cirrhotic cardiomyopathy remains unclear. Structural myocardial changes including diffuse fibrosis may be…”
Get full text

Association of low mechano-energitic efficiency and prognosis in liver cirrhosis by Sjöstedt, Sannia, Wiese, Signe, Bendtsen, Flemming, Møller, Søren

Get full text

Cardiac dysfunction in patients with cirrhosis and acute decompensation by Gananandan, Kohilan, Wiese, Signe, Møller, Søren, Mookerjee, Rajeshwar P.

“…The prevalence of cirrhotic cardiomyopathy (CCM) has been reported as high as 60%–70% in patients with liver cirrhosis and is associated with various negative…”
Get full text

Bile acids and cardiovascular function in cirrhosis by Voiosu, Andrei, Wiese, Signe, Voiosu, Theodor, Bendtsen, Flemming, Møller, Søren

“…Cirrhotic cardiomyopathy and the hyperdynamic syndrome are clinically important complications of cirrhosis, but their exact pathogenesis is still partly…”
Get full text

The composition of the bile acid pool is closely associated with fibrosis in the heart and liver of patients with cirrhosis by Wiese, Signe, Hove, Jens, Ytting, Henriette, Hansen, Svend Hoime, Møller, Søren, Bendtsen, Flemming

Get full text

WED-331-YI Subclinical myocardial fibrosis is related to disease severity in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) by Nabilou, Puria, Wiese, Signe, Hetland, Liv, Werge, Mikkel, Thing, Mira, Rashu, Elias, Junker, Anders, Barløse, Mads, Siebner, Hartwig, Møller, Søren, Bendtsen, Flemming, Gluud, Lise Lotte, Hove, Jens

Get full text

Renal and circulatory effects of terlipressin in patients with hepatorenal syndrome assessed by magnetic resonance imaging by Danielsen, Karen Vagner, Hove, Jens, Nabilou, Puria, Kronborg, Thit, Wiese, Signe, Siebner, Hartwig R., Møller, Søren, Bendtsen, Flemming

Get full text

Peptidylglycine alpha-amidating monooxygenase and adrenomedullin measurements suggest cardio-circulatory dysfunction in advanced cirrhosis by Møller, Søren, Voiosu, Andrei, Wiese, Signe, Schulte, Janun, Kaufmann, Paul, Bergmann, Andreas, Bartels, Emil, Goetze, Jens Peter

Get full text

Increased levels of soluble mannose receptor are associated with poor outcome in cirrhosis: results from a 2-year longitudinal study by Wiese, Signe, Hove, Jens, Møller, Holger Jon, Bendtsen, Flemming, Grønbæk, Henning, Møller, Søren

Get full text

SAT218 - Increased levels of soluble mannose receptor are associated with poor outcome in cirrhosis: results from a 2-year longitudinal study by Wiese, Signe, Hove, Jens, Møller, Holger Jon, Bendtsen, Flemming, Grønbæk, Henning, Møller, Søren

Get full text

Association of low mechano‐energetic efficiency and prognosis in liver cirrhosis by Sjöstedt, Sannia, Wiese, Signe, Bendtsen, Flemming, Møller, Søren

“…Background In cirrhosis, cardiac systolic dysfunction as part of cirrhotic cardiomyopathy affects prognosis. Myocardial mechano‐energetic efficiency (MEE) is…”
Get full text

Low ascitic fluid total protein levels is not associated to the development of spontaneous bacterial peritonitis in a cohort of 274 patients with cirrhosis by Mo, Silje, Bendtsen, Flemming, Wiese, Signe Skovgaard, Kimer, Nina

“…Background: Spontaneous bacterial peritonitis (SBP) is a complication to decompensated cirrhosis. Fluoroquinolones may prevent SBP. However, predictive markers…”
Get full text

Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosis by Wiese, Signe, Danielsen, Karen V., Busk, Troels, Hove, Jens D., Ytting, Henriette, Hansen, Svend Høime, Andersen, Klaus Kaae, Voiosu, Andrei, Møller, Søren, Bendtsen, Flemming

“…Summary Background Elevated serum bile acids (BA) are harmful to the heart and alterations in the BA composition have been suggested to cause cardiovascular…”
Get full text

An update on cirrhotic cardiomyopathy by Møller, Søren, Danielsen, Karen V, Wiese, Signe, Hove, Jens D, Bendtsen, Flemming

“…Cirrhosis with portal hypertension and related complications are associated with a high mortality. Excess of circulating vasodilators and cardiodepressive…”
Get more information

Effect of beta-blockers on multiple haemodynamics in cirrhosis: A cross-over study by MR-imaging and hepatic vein catheterization by Danielsen, Karen Vagner, Nabilou, Puria, Wiese, Signe Skovgaard, Hove, Jens Dahlgaard, Bendtsen, Flemming, Møller, Søren

“…Non-selective beta-blockers (NSBB) are widely used in the treatment of patients with cirrhosis. Only about 50% respond with a sufficient reduction in their…”
Get full text

FRI-130-Changes in the extracellular matrix of the heart and the liver assessed by MRI with T1-mapping are closely linked in cirrhosis: Is inflammation the shared pathway? by Wiese, Signe, Voiosu, Andrei, Hove, Jens, Andersen, Ove, Bendtsen, Flemming, Møller, Søren

Get full text